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ABSTRACT
Objective: Acute respiratory infections (ARIs) are acute infections of any part of the respiratory tract and related structures including middle ear, 
paranasal sinuses, and pleural cavity. This study was to determine the resistance in isolates of the pathogen of the patients with ARIs in clinics in 
Tasikmalaya against antibiotic ciprofloxacin and effectiveness of this antibiotic.
Methods: Isolates were obtained from swabs cavity of 332 patients with ARIs. Ciprofloxacin resistance against pathogenic isolates of diseased 
patients ARIs was determined using paper disk diffusion method.
Results: The patient isolates shows that it is resistance to the antibiotic ciprofloxacin with the percentage of 19.81%.
Conclusion: Ciprofloxacin level of antibiotic resistance being mediated resistance. Routine surveillance and education to health professionals and 
patients are very important to overcome the problem.
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INTRODUCTION
Acute respiratory infections (ARIs) are a leading cause of morbidity and 
mortality of infectious diseases in the world. Nearly, four million people 
worldwide die each year due to respiratory infection. The mortality is 
very high in infants, children, and elderly people, especially in countries 
with low per capita income and middle [1].
Antibiotic usage resistance rates vary from one country to another [2]. 
It is observed that countries with the highest per capita antibiotic 
consumption have the highest resistance rates. It is not only the amount 
of antibiotic used that select for resistance but also the number of 
individuals receiving the drug and the population density also matters [3].
In Tasikmalaya, Indonesia, the main causes of infant and child mortality 
are respiratory infections. In this case, pneumonia is the disease 
that needs the main priority to control in health development in 
Tasikmalaya, West Java [4].
ARIs are the main target therapies to overcome bacterial infections 
because the etiology of respiratory bacteria and viruses that cause 
infection are the second most frequent causes of respiratory infection 
[5,6].
Antibiotics are used to treat the infection. One of the antibiotics that 
used for the treatment of ARIs is ciprofloxacin. Ciprofloxacin has a 
broad spectrum of activity and is active against many organisms that 
are resistant to penicillin, cephalosporins, and aminoglycosides [7]. 
Initially, ciprofloxacin has been successfully used to treat infections 
caused by Gram-negative and Gram-positive organisms and resistance 
case was rare [8].
Reduced susceptibility to fluoroquinolones has become a major 
problem, mostly in Asia [9,10]. There are several reports which alert 
on the customary dispensing of fluoroquinolone of the pathogenic 
bacteria [11]. Currently, antibiotic therapy is often misused as a result 
of irrational use and ease of people to obtain antibiotics without a 
prescription. It triggers the high multidrug resistance [2]. The use of 
antibiotics repeatedly and improperly is the main ones as over the 
counter drugs, which may lead to increased resistance cause of the 
increase in the number of bacteria that are resistant to antibiotics [12].
MATERIALS AND METHODS
Tools
The tools used in this study is the autoclave (Hirayama), volume 
micropipette 5-1000 mL (Eppendorf), tip micropipette, incubator 
(Sakura IF-4), laminar air flow, calipers, burners spritus, ose, sterile 
cotton bud, and glassware tools.
Materials
Materials used in this study consisted of antibiotic, bacterial testing, 
and bacterial growth media.
Test materials
Materials tested were ciprofloxacin from PT. Bernofarm used in 
community health center in Tasikmalaya, West Java, Indonesia. 
McFarland standard No. 0.5 (Merck, USA), and physiological saline 
0.9%.
Bacteria test
Test bacteria used are pathogenic isolates from swabs cavity patients 
at the community health center Taman Sari, Cibeureum Tasikmalaya, 
West Java.
Bacterial growth media
Bacteria growth medium used was Mueller Hinton Agar (MHA) 
(Merck) with a concentration of 43 g/l and Mueller Hinton Broth (Oxid, 
Basingstoke, UK) at a concentration of 21 g/l, MHA (Merck, USA) with a 
concentration of 43 g/l.
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Method
Sample size
The study population is drawn from a patient who has been diagnosed 
by a doctor at the health center. The ARIs patients are patients who seek 
treatment at community health center in Taman Sari and Cibeureum, 
Tasikmalaya, Indonesia, with a period from March to June 2015.
1. Criteria for inclusion are the patients who were diagnosed with ARI 
by doctors at community health centers, Taman Sari and Cibereum 
from March to June 2015.
2. Exclusion criteria that patients with other complications.










P: Proportion category = 0.5
Q: 1-P = 0.5
D: Precision = 0.06.
The use of precision numbers 0.06 aims for the closeness with which 
results of replicate analyses of a sample agree.
In this study, the desired confidence level of 95% so that the value of 
α is 5% and the Z is 1.96 while the acceptable error (value d) by 6%. 
Thus, the required sample size (N) is 266 samples. In this study, the 
sample size used was 332 it aims to obtain more accurate data so that 
the research results will be better.
Inoculation of pathogens
Patients are first examined by a doctor at the health center, after a 
positive diagnosis of patients suffering from disorders ARIs then 
directed to a laboratory to take a swab of the oral cavity upper portion.
Inoculation is done after the patient’s oral swabs were incubated for 
18-24 hrs at 37°C by taking a swab using a sterile loop and streaked 
onto agar slant. Incubate back at 37°C for 18-24 hrs.
Isolation technique pathogens
Isolation of bacteria is done in stages as follows:
a. Making test medium.
 A total of 19 g of Mueller-Hinton order was dissolved in 500 ml of 
distilled water and then sterilized using an autoclave at a temperature 
of 121°C for 15 minutes. The medium can be stored at 4°C.
b. Isolation of bacteria.
 Pathogenic bacterial isolates from the patient’s mouth to be 
inoculated pathogenic bacteria were isolated by scraping the use 
ose upward growth media MHA. Bacterial isolates of the pathogen 
would be isolated to form a color, the structure of the colony, as well 
as the morphology of the same.
Testing pathogen resistance isolates from oral swabs
Testing of antibiotic resistance through several stages:
a. Sample preparation
 Ciprofloxacin dosage equivalent to 100 mg were weighed and added 
to distilled water until dissolved and then added to a buffer solution 
of D3 up to 100 ml. Further dilution to reach a concentration of 
5 µg/ml. D3 solution was prepared by as much as 16.73 g potassium 
phosphate dibasic and 0.523 g of potassium phosphate monobasic 
dissolved in 1 l of distilled water. pH was adjusted to 8.0±0.1 with 
phosphoric acid or potassium hydroxide 18 N 10 N.
b. Resistance test
 Methods for determining the diameter of inhibition zone are the 
agar diffusion method with paper discs techniques. The inhibition 
diameter is measured using a caliper formed as a parameter for 
determining the resistance of bacteria to antibiotic tested.
RESULTS AND DISCUSSION
Sample test results
The number of samples obtained swabs from ARI patients from clinics 
are 332 samples can be seen in Table 1.
Both the number of samples that can be used to test the resistance 
and identification totaled 308, while the number of defective samples 
totaling 24. The sample is a sample which is damaged during the 
incubation period there is no bacterial growth. This can be caused by 
several factors such as errors in sampling as clinics officers no cotton 
buds moistened with sterile distilled water in advance, or cotton 
buds are not on the surface of the patient’s oral cavity and the sample 
damaged by temperatures that are too hot at the time of transport.
Samples isolate patients with ARIs taken from Clinics in Tasikmalaya 
using test tubes to be skewed. Before isolation using test tubes for 
oblique and resistance tests, all equipment must be sterilized in advance 
to avoid microorganisms that could interfere with the results of testing. 
To test tube slant that has been sent to the clinics in Tasikmalaya then 
used a sterile swab tool to take sputum isolates of patients with ARIs 
and streaked onto agar slant that has been provided. After that, the 
oblique order was brought to the Laboratory of Microbiology, Faculty 
of Pharmacy, University of Padjadjaran and directly incubated in an 
incubator. The samples were incubated at 37°C for 18-24 hrs and then 
removed and tested resistance to ciprofloxacin.
Resistance test results
Test of resistance to ciprofloxacin performed using paper disc method. 
The paper disc method chosen because this method is more simple and 
have high accuracy. In addition, this method can also save processing 
time because the samples used in large numbers. In addition, the paper 
disc method can also save processing time because the samples used 
in large numbers. Paper disc method is also more accurate because it 
uses a fixed concentration in the paper discs which reduce errors while 
doing resistance tests.
Results of the test of resistance can be observed by inhibition zone is 
formed. The inhibition zone is a clear area formed around the paper 
disk which indicated that bacteria cannot grow around the paper disc 
area. This test is intended to determine whether antibiotics are still 
sensitive to the test bacterium. Inhibition zone accepted as a guide in 
determining if something is still effective drugs used can be seen in 
Table 2.
Samples of bacteria from the oral cavity of patients tested was dissolved 
in physiological saline so that the color is muddy, bacteria in the solution 
of NaCl is compared to 0.5 McFarland turbidity. After that, 20 ml of 
bacteria in a solution of NaCl is taken using a micropipette is inserted 
into a sterile petri dish that contains 20 ml MHA. Bacteria in the solution 
Table 1: Research samples














Samples total amount 308 24















Ciprofloxacin 5 <19 17-21 ≥22
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of NaCl which has been incorporated into the entire portion is flattened 
so that in a petri dish using a spreader so average. Put each paper disc 
that contains the antibiotic as much as 20 µl using a micropipette.
The paper disc is inserted into an agar medium in a petri dish using 
tweezers under aseptic state to each of the allotted portion. After 
incubated for 18-24 hrs at 37°C in the incubation chamber. After that 
the observed inhibition zone diameter is formed on the surface so 
that in a petri dish that has been incubated. Inhibitory zone diameters 
were measured using calipers, and the value of inhibition zone was 
noted. Antibiotics used are antibiotic used in Clinics in Tasikmalaya 
for ARIs patients that this study can be seen from antibiotics which 
are still effective for use in Clinics in Tasikmalaya. Antibiotic used to 
be reconstituted and diluted by a predetermined dose. The number of 
samples that are resistant to ciprofloxacin can be seen in Table 3.
The test results of resistance that can be seen in Table 3 show that as 
many as 308 samples from clinical isolates were tested; the samples 
that are resistant to ciprofloxacin are 61 samples.
Using stratified random sampling (SRS) technique, the sample was 
divided into two stratum based on clinics which were chosen as the 
source of the isolates. To determine the proportion percentage of the 
resistance in Tasikmalaya, the researcher used proportion valuation 
techniques. Estimation for the proportion also involves massive 
proportions for each stratum. Therefore, through an SRS of size N, 














Xij = 1 if the sampling unit has the characteristics (resistant)
Xij = 0 if the sampling unit does not have the characteristic (sensitive).





















 =0.1981 from 1
With 95% level of confidence, the percentage of resistance to the 
antibiotic ciprofloxacin in Tasikmalaya is 19.81%.
There are several factors that can cause bacterial resistance to antibiotics, 
including changes in the structure of the bacteria so that the bacteria 
have modified themselves; it can produce enzymes that can inactivate 
drugs [13]. Another factor that can affect antibiotic resistance is the misuse 
of antibiotics in which the drug is administered though the indications are 
not clear. In addition, this is due to repeated use of antibiotics and patients 
not adhering to the appropriate dose of antibiotic use. [12].
Many studies have shown that educational/training interventions, 
whether conducted in large or small groups, can successfully improve 
targeted antibiotic prescribing patterns by an average of 20% or more 
if they are well designed [14].
The effectiveness of peer education is enhanced when the message is 
delivered or endorsed by local opinion leaders and made relevant to the 
doctor’s own practice [15,16]. Providing feedback to clinicians regarding 
their own antibiotic prescribing practices has been a successful 
technique for achieving behavior change [16]. Feedback entails 
comparisons with peers or with a standard or indicator [17].
Several factors favor the development of bacterial resistance to 
antibiotics in developing countries:
1. Less potent activity: Some of the antibiotics provided in developing 
countries have decreased potency because of degradation or 
adulteration of the drug, or because of the presence of a lower 
concentration of active substances [7,18,19].
2. Lack of diagnostic laboratories: Most of the hospitals in developing 
countries do not have clinical microbiology laboratories to perform 
routine analyses for microbiological diagnosis.
3. Over-the-counter availability: In most developing countries, 
antibiotics can be purchased without a prescription in pharmacies, 
general stores, markets, and from street hawkers [11].
CONCLUSION
From this study, it can be concluded that there has been resistance in 
pathogenic isolates from the oral swab of ARIs patients at community 
health center of Taman Sari and Cibereum Tasikmalaya, West Java, 
Indonesia to the antibiotic ciprofloxacin as much as 19.81%.
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